Drugs Recalls

Chemical contamination: product contains elevated levels of undeclared lead.

Chemical contamination: product contains elevated levels of undeclared lead.

Chemical contamination: product contains elevated levels of undeclared lead.

Microbial contamination of non-sterile products: positive microbial contamination in product.

Chemical contamination: product contains elevated levels of undeclared lead.

Chemical contamination: product contains elevated levels of undeclared lead.

Chemical contamination: product contains elevated levels of undeclared lead.

Lack of Processing Controls (lack of assurance of conformity to specifications).

Lack of Processing Controls (lack of assurance of conformity to specifications).

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.

SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.

Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

Lack of Processing Controls (lack of assurance of conformity to specifications).

Lack of Processing Controls (lack of assurance of conformity to specifications).

Lack of Processing Controls (lack of assurance of conformity to specifications).

Lack of Processing Controls (lack of assurance of conformity to specifications).

Chemical Contamination: Product contains undeclared methanol.

Subpotent Drug: Product was found to be subpotent. Product also has high pH levels

Lack of Processing Controls (lack of assurance of conformity to specifications).